CO5611144A2 - Uso de 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas sustituidas para producir medicamentos con un efecto inhibidor sobre la lipasa pancreatica - Google Patents
Uso de 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas sustituidas para producir medicamentos con un efecto inhibidor sobre la lipasa pancreaticaInfo
- Publication number
- CO5611144A2 CO5611144A2 CO04083781A CO04083781A CO5611144A2 CO 5611144 A2 CO5611144 A2 CO 5611144A2 CO 04083781 A CO04083781 A CO 04083781A CO 04083781 A CO04083781 A CO 04083781A CO 5611144 A2 CO5611144 A2 CO 5611144A2
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- groups
- substituted
- alkyloxy
- aryl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10208986A DE10208986A1 (de) | 2002-02-28 | 2002-02-28 | Verwendung substituierter 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one zur Herstellung von Arzneimitteln mit hemmender Wirkung an der pankreatischen Lipase |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5611144A2 true CO5611144A2 (es) | 2006-02-28 |
Family
ID=27740557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO04083781A CO5611144A2 (es) | 2002-02-28 | 2004-08-26 | Uso de 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas sustituidas para producir medicamentos con un efecto inhibidor sobre la lipasa pancreatica |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1482929A1 (fr) |
JP (1) | JP2005519079A (fr) |
KR (1) | KR20040101250A (fr) |
CN (1) | CN1638766A (fr) |
AR (1) | AR038702A1 (fr) |
AU (1) | AU2003210292A1 (fr) |
BR (1) | BR0308045A (fr) |
CA (1) | CA2477005A1 (fr) |
CO (1) | CO5611144A2 (fr) |
DE (1) | DE10208986A1 (fr) |
HR (1) | HRP20040783A2 (fr) |
HU (1) | HUP0500093A2 (fr) |
IL (1) | IL163719A0 (fr) |
MA (1) | MA27173A1 (fr) |
MX (1) | MXPA04007480A (fr) |
NO (1) | NO20044091L (fr) |
PL (1) | PL371310A1 (fr) |
RU (1) | RU2004128932A (fr) |
TW (1) | TW200400026A (fr) |
WO (1) | WO2003072098A1 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI359812B (en) | 2004-06-17 | 2012-03-11 | Cytokinetics Inc | Compounds, compositions and methods |
MX2007004889A (es) | 2004-10-25 | 2007-09-11 | Solvay Pharm Gmbh | Composiciones farmaceuticas que comprenden antagonistas del receptor cannabinoide cb1 y activadores de canales de potasio para el tratamiento de la diabetes mellitus tipo i, la obesidad y trastornos relacionados. |
TW200808321A (en) | 2005-12-15 | 2008-02-16 | Cytokinetics Inc | Certain chemical entities, compositions and methods |
US7825120B2 (en) | 2005-12-15 | 2010-11-02 | Cytokinetics, Inc. | Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas |
JP5178526B2 (ja) | 2005-12-19 | 2013-04-10 | サイトキネティクス・インコーポレーテッド | 化合物、組成物および方法 |
KR101613610B1 (ko) * | 2007-12-25 | 2016-04-19 | 깃세이 야쿠힌 고교 가부시키가이샤 | 신규한 카테콜 유도체, 그것을 함유하는 의약 조성물 및 그것들의 용도 |
WO2010074587A2 (fr) | 2008-12-23 | 2010-07-01 | Bial - Portela & Ca., S.A. | 3-n-aryl-1,3,4-oxadiazolones 5-o-substituées destinées à une utilisation médicale |
CN103086859B (zh) * | 2011-11-08 | 2015-11-11 | 清华大学 | 2,4-二羟基-5,6-取代-1-卤代苯衍生物、其合成方法及其应用 |
EP3676243A4 (fr) * | 2017-09-01 | 2021-05-26 | Curtin University | Dérivés synthétiques de oléoyl-lysophosphatidylinositol (oléolyl-lpi) et utilisations associées |
CN109879839B (zh) * | 2019-03-12 | 2023-04-25 | 沈阳大学 | 6-哌嗪甲基-7-羟基苯并呋喃类化合物及其医药用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19942354A1 (de) * | 1999-09-04 | 2001-03-08 | Aventis Pharma Gmbh | Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln |
HUP0302772A3 (en) * | 2000-03-07 | 2007-03-28 | Sanofi Aventis Deutschland | Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase |
-
2002
- 2002-02-28 DE DE10208986A patent/DE10208986A1/de not_active Withdrawn
-
2003
- 2003-02-17 HU HU0500093A patent/HUP0500093A2/hu unknown
- 2003-02-17 KR KR10-2004-7013470A patent/KR20040101250A/ko not_active Application Discontinuation
- 2003-02-17 CA CA002477005A patent/CA2477005A1/fr not_active Abandoned
- 2003-02-17 WO PCT/EP2003/001560 patent/WO2003072098A1/fr not_active Application Discontinuation
- 2003-02-17 JP JP2003570844A patent/JP2005519079A/ja not_active Withdrawn
- 2003-02-17 PL PL03371310A patent/PL371310A1/xx not_active Application Discontinuation
- 2003-02-17 CN CNA038047675A patent/CN1638766A/zh active Pending
- 2003-02-17 MX MXPA04007480A patent/MXPA04007480A/es unknown
- 2003-02-17 EP EP03742942A patent/EP1482929A1/fr not_active Withdrawn
- 2003-02-17 AU AU2003210292A patent/AU2003210292A1/en not_active Abandoned
- 2003-02-17 RU RU2004128932/15A patent/RU2004128932A/ru not_active Application Discontinuation
- 2003-02-17 IL IL16371903A patent/IL163719A0/xx unknown
- 2003-02-17 BR BR0308045-5A patent/BR0308045A/pt not_active Application Discontinuation
- 2003-02-26 TW TW092103972A patent/TW200400026A/zh unknown
- 2003-02-26 AR ARP030100625A patent/AR038702A1/es unknown
-
2004
- 2004-07-27 MA MA27804A patent/MA27173A1/fr unknown
- 2004-08-26 CO CO04083781A patent/CO5611144A2/es not_active Application Discontinuation
- 2004-08-27 HR HR20040783A patent/HRP20040783A2/hr not_active Application Discontinuation
- 2004-09-27 NO NO20044091A patent/NO20044091L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2004128932A (ru) | 2005-04-10 |
HRP20040783A2 (en) | 2005-04-30 |
HUP0500093A2 (hu) | 2005-04-28 |
DE10208986A1 (de) | 2003-09-11 |
TW200400026A (en) | 2004-01-01 |
PL371310A1 (en) | 2005-06-13 |
KR20040101250A (ko) | 2004-12-02 |
AU2003210292A1 (en) | 2003-09-09 |
CN1638766A (zh) | 2005-07-13 |
JP2005519079A (ja) | 2005-06-30 |
NO20044091L (no) | 2004-09-27 |
IL163719A0 (en) | 2005-12-18 |
MA27173A1 (fr) | 2005-01-03 |
WO2003072098A1 (fr) | 2003-09-04 |
BR0308045A (pt) | 2004-12-21 |
MXPA04007480A (es) | 2004-11-10 |
CA2477005A1 (fr) | 2003-09-04 |
AR038702A1 (es) | 2005-01-26 |
EP1482929A1 (fr) | 2004-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5611144A2 (es) | Uso de 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas sustituidas para producir medicamentos con un efecto inhibidor sobre la lipasa pancreatica | |
CO4650042A1 (es) | Derivados de 6-fenilpiridil-2-amina | |
CO4950619A1 (es) | Derivados de acido arilsulfonil hidroxamico | |
CO5690597A2 (es) | Derivados de hexahidropirazino[1,2-a]pirimidina-4,7-diona sustituidos, metodo para producirlos y sus uso cxomo medicamentos | |
CO5021127A1 (es) | Nuevas dihidropirimidas | |
AR015765A1 (es) | Dihidropirimidinas 2 heterociclicamente sustituidas, proceso para su preparacion, medicamentos que los contienen, proceso para la preparacion de los mismosuso de dichos dihidropirimidinas para la preparacion de un medicamento. | |
CO5261626A1 (es) | Glutarimidas sustituidas, su preparacion, medicamentos que las contienen, y uso de las mismas para la fabricacion de medicamentos, especialemente inmunomoduladores, como asi tambien inhibidores de angiopatias y/o enfermedades hematologicas/oncologica | |
AR025884A1 (es) | Compuestos de amina ciclica, su produccion y su uso | |
CR8595A (es) | Inhibidor del dipeptidil-peptidasa | |
BRPI0508464B8 (pt) | sulfonilpirróis, composição farmacêutica compreendendo os mesmos e uso dos mesmos | |
CO6160235A2 (es) | Isoxazolinas insecticidas | |
ES2436020T3 (es) | Derivados de sulfonamida sustituidos | |
DK0494819T3 (da) | Hidtil ukendte phenylimidazolidiner, deres fremstilling, anvendelse som lægemidler samt farmaceutiske præparater med indhold heraf | |
ECSP099062A (es) | Derivados novedosos de aminopiridina que tienen acción inhibidora selectiva sobre aurora a | |
ES2150671T3 (es) | Compuesto de bencimidazol y su utilizacion como moduladores del complejo de receptores gaba-a. | |
DK157295C (da) | Tetrahydrobenzindoler og deres anvendelse som laegemidler | |
NO20072005L (no) | Nye heterocykliske amider | |
CO4810374A1 (es) | Nueva utilizacion de compuestos para actividad anti- pruritica | |
AR042362A1 (es) | Derivados de 3h-quinazolin-4-ona, proceso de obtencion y composiciones farmaceuticas que los contienen | |
CO6160310A2 (es) | Nuevos derivados imidazolonas su preparacion como medicamentos composiciones farmaceuticas utilizacion como inhibidores de proteinas quinasas principalmente cdc7 | |
AR016644A1 (es) | Compuestos de 2-aminopiridinas con sustituyentes alcoxi ramificados, composicion farmaceutica y uso para la manufactura de medicamentos | |
AR007088A1 (es) | 2,4-diaminopirimidinas sustituidas, compuestos intermedios utilizados en su preparacion, procedimiento para la preparacion de dichas 2,4-diaminopirimidinas sustituidas, medicamentos que las contienen y empleos de dichas pirimidinas | |
HUP0202988A2 (hu) | Szubsztituált 3-fenil-5-alkoxi-1,3,4-oxadiazol-2-on-származékok és lipán inhibitorként történő alkalmazásuk, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
ES2165193T3 (es) | Metodo para aumentar la actividad de una enzima. | |
ES2185316T3 (es) | Butirolactonas alfa, beta-condensadas sustituidas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |